---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-025596"
form_type: "8-K"
ticker: "ATOS"
cik: "0001488039"
company_name: "ATOSSA THERAPEUTICS, INC."
filed_at: "2025-02-24T23:59:59+00:00"
generated_at: "2026-05-26T05:45:51.146167+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Atossa receives Nasdaq minimum bid price deficiency notice; compliance period through Aug 20, 2025

## Summary
- Received Nasdaq deficiency notice on Feb 21, 2025 for failing to maintain $1.00 minimum bid price for 30 consecutive business days.
- Compliance period ends Aug 20, 2025; possible additional 180-day extension if not compliant by then.
- To regain compliance, common stock must close at $1.00+ for at least 10 consecutive business days.
- Notice has no immediate effect on stock listing or trading; company monitoring and evaluating options.

## SEC filing metadata
- accession: 0000950170-25-025596
- form_type: 8-K
- ticker: ATOS
- cik: 0001488039
- company_name: ATOSSA THERAPEUTICS, INC.
- filed_at: 2025-02-24T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1488039/000095017025025596/0000950170-25-025596-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1488039/000095017025025596/atos-20250221.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-025596
- JSON: https://secwatch.observer/filing/0000950170-25-025596.json
- Plain text: https://secwatch.observer/filing/0000950170-25-025596.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.